Aspirin reduces long-term colorectal cancer risk in genetically predisposed individuals

(University of Jyv ä skyl ä - Jyv ä skyl ä n yliopisto) Aspirin reduces colorectal cancer risk by half in individuals at high genetic risk. Preventive efficacy is prolonged for 10-20 years after treatment with aspirin.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news